Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Replay
Cowen and Company 35th Annual Health Care Conference
03/02/15 at 2:10 p.m. ET
Cowen and Company 35th Annual Health Care Conference
Monday, March 2, 2015 2:10 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Press Releases
More >>
03/25/15
ARIAD Announces Dismissal of Shareholder Class Action Lawsuit in Federal District Court
03/24/15
ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel
Investor Downloads

Download Documentation Investor Presentation
More >>

ARIAD Stock Price: $8.39

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 03/27/15

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Up 0.22 (2.69%)
VOL4,653,544
OPEN$8.24
PREV. CLOSE$8.17
DAY HIGH$8.45
DAY LOW$8.17
52 WK. HIGH$9.19
Minimum 20 minute delay
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue